Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect

Journal of Food and Drug Analysis

Volumn 16, Issue 3, 2008, Pages 6-14

  Khan, Arif Ullah ^a,b   Gilani, Anwarul Hassan ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Antihypertensive; Ca++ antagonist; Terminalia bellerica

Indexed keywords

CALCIUM ION; FLAVONOID; N(G) NITROARGININE METHYL ESTER; PLANT EXTRACT; STEROL; TANNIN; TERMINALIA BELLERICA EXTRACT; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CALCIUM ANTAGONISM; CALCIUM TRANSPORT; CHEMICAL COMPOSITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; GUINEA PIG; HEART ATRIUM CONTRACTION; HYPERTENSION; MALE; MAMMARY ARTERY; NONHUMAN; PHARMACODYNAMICS; RABBIT; RAT; TERMINALIA; TERMINALIA BELLERICA; VASCULAR ENDOTHELIUM;

CAVIA; ORYCTOLAGUS CUNICULUS; RATTUS; TERMINALIA BELLIRICA;

EID: 50449099459     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kapoor, L. D. 1990. Handbook of Ayurvedic Medicinal Plants. p. 321. CRC Press. Boca Raton, U. S. A.
2. Duke, J. A., Bogenschutz-Godwin, M. J., Ducelliar, J. and Duke, P. A. K. 2002. Handbook of Medicinal Herbs. 2nd ed. pp. 70-71. CRC Press. Boca Raton, U. S. A.
3. Usmanghani, K., Saeed, A. and Alam, M. T. 1997. Indusyunic Medicine. pp. 420-421. University Press. Karachi, Pakistan.
4. Valsaraj, R., Pushpangadan, P., Smitt, U. W., Adsersen, A., Christensen, S. B., Sittie, A., Nyman, U., Nielsen, C. and Olsen, C. E. 1997. New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J. Nat. Prod. 60: 739-742.
5. Anand, K. K., Singh, B., Saxena, A. K., Chandan, B. K., Gupta, V. N. and Bhardwaj, V. 1997. 3,4,5-trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia bellerica-bioassay guided activity. Pharmacol. Res. 36: 315-321.
6. Nandy, A. K., Podder, G., Sahu, N. P. and Mahato, S. B. 1989. Triterpenoids and their glucosides from Terminalia bellerica. Phytochemistry 28: 2769-2772.
7. Yadava, R. N. and Rathore, K. 2001. A new cardenolide from the seeds of Terminalia bellerica. Fitoterapia 72: 310-312.
8. Shaila, H. P., Udupa, A. L. and Udupa, S. L. 1995. Preventive actions of Terminalia bellerica in experimentally induced atherosclerosis. Int. J. Cardiol. 49: 101-106.
9. Ahmad, I., Mehmood, Z. and Mohammad, F. 1998. Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol. 62: 183-193.
10. El-Mekkawy, S., Mesełhy, M. R., Kusmoto, I. T., Kadota, S., Hattori, M. and Namba, T. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem. Pharm. Bull. 43: 641-648.
11. Bajpai, M., Pande, A., Tewari, S. K. and Dhan, P. 2005. Phenolic contents and antioxidant activity of some food and medicinal plants. Int. J. Food Sci. Nutr. 56: 287-291.
12. Sabu, M. C. and Kuttan, R. 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J. Ethnopharmacol. 81: 155-160.
13. Tariq, M., Hussain, S. J., Asif, M. and Jahan, M. 1977. Protective effect of fruit extracts of Emblica officinalis (Gaertn). & Terminalia bellerica (Roxb.) in experimental myocardial necrosis in rats. Indian J. Exp. Biol. 15: 485-486.
14. Anand, K. K., Singh, B., Saxena, A. K., Chandan, B. K. and Gupta, V. N. 1994. Hepatoprotective studies of a fraction from the fruits of Terminalia bellerica Roxb. on experimental liver injury in rodents. Phytother. Res. 8: 287-292.
15. Srivastava, R. D., Dwivedi, S., Sreenivasan, K. K. and Chandrashekhar, C. N. 1992. Cardiovascular effects of Terminalia species of plants. Indian Drugs 29: 144-149.
16. Dwivedi, S., Pachori, S. B. and Amrita. 1994. Medicinal plants with hypotensive activity. Indian Pract. 6: 117-134.
17. Williamson, E. M., Okpako, D. T. and Evans, F. J. 1998. Selection, Preparation and Pharmacological Evaluation of Plant Material. pp. 15-23. John Wiley & Sons. Chichester, England.
18. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. pp. 1-7. National Academy Press. Washington, U. S. A.
19. Harborne, J. B. 1984. Phytochemical Methods. 2nd ed. p.73-89. Chapman and Hall. New York, U. S. A.
20. Evans, W. C. 1996. Trease and Evan's Pharmacognosy. 14th ed. pp. 161-408. WB Sounders. London, U. K.
21. Akinyemi, O. K., Oladapo, O., Okwara, C. E., Ibe, C. C. and Fasure, K. A. 2005. Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity. BMC Complement. Altern. Med. 5: 6.
22. Singleton, V. L., Orthofer, R. and Lamuela-Raventos, R. M. 1999. Analysis of total phenols and other oxidation substrates and oxidants by means of Folin-Ciocalteu Reagent. Meth. Enzymol. 299: 152-178.
23. Huang, D. J., Lin, C. D., Chen, H. J. and Lin, Y. H. 2004. Antioxidant and antiproliferative activities of sweet potato (Ipomoea batatas [L.] Lam 'Tainong 57') constituents. Bot. Bull. Accad. Sin. 45: 179-186.
24. Gilani, A. H. 1991. Antihypertensive activity of himbacine in anaesthetized cats. Drug Dev. Res. 24: 127-133.
25. Tanaka, M., Masumiya, H., Sekine, T., Sijuku, T., Sugahara, M., Taniguchi, H., Terada, M., Saito, W. and Shigenobu, K. 1996. Mycordial and vascular effects of efonidipine in vitro as compared with nifidipine, verapamil and diltiazem. Gen. Pharmacol. 27: 451-454.
26. Gilani, A. H., Ghayur, M. N., Houghton, P. J., Jabeen, Q., Kazim, S. F., Jumani, M. I. and Saeed, S. A. 2006. Studies on the hypotensive, cardio-suppressant, vasodilator and antiplatelet activities of betel nut crude extract and its constituents. Int. J. Pharmacol. 2: 33-41.
27. Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. 1997. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49: 157-230.
28. Wang, G. J., Shum, A. Y., Lin, Y. L., Liao, J. F., Wu, X. C., Ren, J. and Chen, C. F. 2001. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus. J. Pharmacol. Exp. Ther. 297: 240-246.
29. Cauvin, C. and Malik, S. 1984. Induction of calcium influx and calcium release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of α-receptors. J. Pharmacol. Exp. Ther. 230: 413-418.
30. Hashimoto, T., Hirata, M., Itoh, T., Kanmura, Y. and Kuriyama, H. 1986. Inositol 1,4,5-triphosphate activates pharmaco-mechanical coupling in smooth muscle of rabbit mesenteric artery. J. Physiol. 370: 605-618.
31. Furchgott, R. F. and Zawadski, J. V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 299: 373-376.
32. Ajay, M., Chai, H. J., Mustafa, A. M., Gilani, A. H. and Mustafa, M. R. 2007. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. J. Ethnopharmacol. 109: 388-393.
33. Johansen, P. L. 1992. Hemodynamic effects of calcium antagonists in hypertension. In "Calcium Antagonists in Clinical Medicine". pp. 62-98. Epstein, M. ed. Hanley and Belfus. Philadelphia, U. S. A.
34. ++ in myocardium, cardiac pacemakers and vascular smooth muscle. Rev. Pharmacol. Toxicol. 17: 149-166.
35. Roden, D. M. 2006. Antiarrhythmic drugs. In "Goodman and Gilman's the Pharmacological Basis of Therapeutics". 11th ed. pp. 899-932. Brunton, L. L., Lazo, J. S. and Parker, K. L. eds. McGraw-Hill. New York, U. S. A.
36. Okmura, K., Ichihara, K., Nagaska, M., Oda, N. and Tajima, K. 1993. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites. Eur. J. Pharmacol. 235: 69-74.
37. Musha, S., Watanabe, M., Ishida, Y., Kato, S., Konishi, M. and Tomoda, A. 2005. A phenoxazine compound, 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one reverses the phenylephrine or high-K+ induced contractions of smooth muscles in rat aorta and guinea-pig tenia cecum. Biol. Pharm. Bull. 28: 1521-1523.
38. Hall, J., Jones, T. H., Channer, K. S. and Jones, R. D. 2006. Mechanisms of agonist-induced constriction in isolated human mesenteric arteries. Vasc. Pharmacol. 44: 427-433.
39. ++ from intracellular stores of the rat portal vein stimulates a tonic contraction. Eur. J. Pharmacol. 510: 97-105.
40. Ghayur, M. N. and Gilani, A. H. 2005. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J. Cardiovasc. Pharmacol. 45: 74-80.
41. Chan, S. S., Choi, A. O., Jones, R. L. and Lin, G. 2006. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong in rat isolated aorta. Eur. J. Pharmacol. 537: 111-117.
42. Thorin, E., Huang, P. L., Fishman, M. C. and Bevan, J. A. 1998. Nitric oxide inhibits alpha2-adrenoceptor mediated endothelium-dependent vasodilation. Circ. Res. 82: 1323-1329.
43. Ajay, M., Gilani, A. H. and Mustafa, M. R. 2003. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci. 74: 603-612.
44. Zhu, M., Phillipson, J. D., Greengrass, P. M., Bowery, N. E. and Cai, Y. 1997. Plant polyphenols: biologically active compounds or non-selective binders to proteins? Phytochemistry 44: 441-447.